Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

ArriVent BioPharma, Inc.

NASDAQ: AVBP · Life Sciences · 6 alerts · CIK 1868279

ArriVent BioPharma, Inc. stories on ALFA USA NewsRead the news →
Share price
$11.56Close, Nov 16
Market cap
$598M
Shares outstanding
51.72MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All ArriVent BioPharma, Inc. filings on SEC EDGAR ↗

6:03 AM ET 8-K
Business Update

ArriVent BioPharma Business Update

ArriVent BioPharma announced the dosing of the first patient in its U.S. Phase 1 clinical trial of ARR-002, a potential first-in-class dual-target antibody-drug conjugate (ADC). The trial is evaluating the safety and efficacy of the candidate in patients with advanced or metastatic ovarian and endometrial cancer.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.